MMedication Read More My Mother Had Alzheimer’s. That’s Why I Started a GLP-1July 15, 2026 As an endocrinologist, I spend much of my day discussing GLP-1 medications with my patients. This week, I…
SScience Read More Scientists create first detailed smell mapMay 15, 2026 Scientists in America have created the first detailed map of the smell receptors in the nose. The study…
MMedication Read More New Drug for Tourette Syndrome Effective for Kids and AdultsOctober 14, 2025 HONOLULU — The investigational dopamine-1 (D1) receptor antagonist ecopipam (developed by Emalex Biosciences) is safe and effective for…
MMedication Read More When GLP-1s Change Patients’ Libido: What to KnowSeptember 30, 2025 It’s not discussed as often as other side effects of GLP-1 receptor agonists, but one adverse effect is…
MMedication Read More FDA Seeks Schedule I Status for ‘Legal Morphine’July 31, 2025 The FDA is recommending that 7-hydroxymitragynine (7-OH), a synthetic, concentrated substance derived from kratom leaves, be classified as…
MMedication Read More Most GLP-1 Prescriptions Miss the Mark: Are Yours?July 28, 2025 GLP-1 receptor agonists, including semaglutide, are now widely used for weight loss, offering substantial weight reduction, improved metabolic…